Safety and Immunogenicity of a Mycobacterium Tuberculosis Vaccine MTBVAC in Healthy Indian Adults and Adolescents (BBV169/2024)
Clinical trial NCT06997367 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06997367
- Sponsor
- Bharat Biotech International Limited
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-27
- Primary completion
- 2025-09-01
- Enrollment
- 164
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.